Lotensin and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is found among people who take Lotensin, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Lotensin and have Weight loss. It is created by eHealthMe based on reports of 7,735 people who have side effects when taking Lotensin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

7,735 people reported to have side effects when taking Lotensin.
Among them, 77 people (1.0%) have Weight loss.

What is Lotensin?

Lotensin has active ingredients of benazepril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 7,928 Lotensin users for its effectiveness, alternative drugs and more.

What is Weight loss?

Weight loss is found to be associated with 2,719 drugs and 2,195 conditions by eHealthMe.

Number of Lotensin and Weight loss reports submitted per year:

Gender of people who have Weight loss when taking Lotensin *:

female: 69.33 %
male: 30.67 %

Age of people who have Weight loss when taking Lotensin *:

Common drugs people take besides Lotensin *:

Common side effects people have besides Weight loss *:

Pain: 35 people, 45.45%
Stress And Anxiety: 35 people, 45.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 32 people, 41.56%
Fall: 31 people, 40.26%
Anaemia (lack of blood): 30 people, 38.96%
Pleural Effusion (water on the lungs): 29 people, 37.66%
Rashes (redness): 29 people, 37.66%
Impaired Healing: 28 people, 36.36%
Swelling: 28 people, 36.36%
Swallowing Difficulty: 28 people, 36.36%

Common conditions people have *:

Pain: 28 people, 36.36%
Breast Cancer: 26 people, 33.77%
Depression: 26 people, 33.77%
Metastases To Bone (cancer spreads to bone): 25 people, 32.47%
Metastasis (spreadable cancer to other organ from origin): 24 people, 31.17%
Oedema (fluid collection in tissue): 14 people, 18.18%
Stress And Anxiety: 4 people, 5.19%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 5.19%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 5.19%
Diabetes: 3 people, 3.90%

* Approximation only. Some reports may have incomplete information.

Do you take Lotensin and have Weight loss?

Check whether Weight loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Weight loss and when was it recovered:

Weight loss in Lotensin

Expand to all the drugs that have ingredients of benazepril hydrochloride:

Weight loss and drugs with ingredients of benazepril hydrochloride (109 reports)

Alternative drugs to, pros and cons of Lotensin:

Lotensin (7,928 reports)

Common Lotensin side effects:

High blood pressure: 633 reports
Pain: 550 reports
Fatigue (feeling of tiredness): 530 reports
Weakness: 503 reports
Chest pain: 498 reports
Drug ineffective: 452 reports

Browse all side effects of Lotensin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Weight loss treatments and more:

Weight loss (50,804 reports)

COVID vaccines that are related to Weight loss:

Common drugs associated with Weight loss:

All the drugs that are associated with Weight loss:

Weight loss (2,719 drugs)

Common conditions associated with Weight loss:

Depression: 2,066 reports
Bipolar disorder: 1,904 reports
Schizophrenia: 1,856 reports
Attention deficit hyperactivity disorder: 1,335 reports
High blood pressure: 1,334 reports
Rheumatoid arthritis: 1,226 reports
Pain: 1,051 reports

All the conditions that are associated with Weight loss:

Weight loss (2,195 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benazepril hydrochloride (the active ingredients of Lotensin) and Lotensin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.